Search filters

List of works by Filippo Spriano

DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas

scientific article published on 07 May 2019

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.

scientific article

Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma.

scientific article published on 27 June 2017

Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas

scientific article published on 29 July 2019

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

scientific article published on 10 June 2019

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax

scientific article published on 04 June 2019

Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma.

scientific article published on 2 April 2018

Paulina is supported by:

About Paulina

Help